Literature DB >> 21955045

Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in mice.

Yue Wu1, Erin L Lousberg, Lachlan M Moldenhauer, John D Hayball, Janet K Coller, Kenner C Rice, Linda R Watkins, Andrew A Somogyi, Mark R Hutchinson.   

Abstract

BACKGROUND AND
PURPOSE: Emerging evidence implicates a role for toll-like receptor 4 (TLR4) in the CNS effects of alcohol. The aim of the current study was to determine whether TLR4-MyD88-dependent signalling is involved in the acute behavioural actions of alcohol and if alcohol can activate TLR4-downstream MAPK and NF-κB pathways. EXPERIMENTAL APPROACH: The TLR4 pathway was evaluated using the TLR4 antagonist (+)-naloxone (µ-opioid receptor-inactive isomer) and mice with null mutations in the TLR4 and MyD88 genes. Sedation and motor impairment induced by a single dose of alcohol were assessed by loss of righting reflex (LORR) and rotarod tests, separately. The phosphorylation of JNK, ERK and p38, and levels of IκBα were measured to determine the effects of acute alcohol exposure on MAPK and NF-κB signalling. KEY
RESULTS: After a single dose of alcohol, both pharmacological inhibition of TLR4 signalling with (+)-naloxone and genetic deficiency of TLR4 or MyD88 significantly (P < 0.0001) reduced the duration of LORR by 45-78% and significantly decreased motor impairment recovery time to 62-88% of controls. These behavioural actions were not due to changes in the peripheral or central alcohol pharmacokinetics. IκBα levels responded to alcohol by 30 min in mixed hippocampal cell samples, from wild-type mice, but not in cells from TLR4- or MyD88-deficient mice. CONCLUSIONS AND IMPLICATIONS: These data provide new evidence that TLR4-MyD88 signalling is involved in the acute behavioural actions of alcohol in mice.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21955045      PMCID: PMC3372718          DOI: 10.1111/j.1476-5381.2011.01572.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  Ethanol-induced activation of AKT and DARPP-32 in the mouse striatum mediated by opioid receptors.

Authors:  Karl Björk; Anton Terasmaa; Hui Sun; Annika Thorsell; Wolfgang H Sommer; Markus Heilig
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and/or motor impairment.

Authors:  Yue Wu; Erin L Lousberg; Lachlan M Moldenhauer; John D Hayball; Sarah A Robertson; Janet K Coller; Linda R Watkins; Andrew A Somogyi; Mark R Hutchinson
Journal:  Brain Behav Immun       Date:  2011-01-27       Impact factor: 7.217

3.  Guide to Receptors and Channels (GRAC), 5th edition.

Authors:  Stephen P H Alexander; Alistair Mathie; John A Peters
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 4.  Alcoholic liver disease and the gut-liver axis.

Authors:  Gyongyi Szabo; Shashi Bala
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

5.  Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome.

Authors:  C Ikonomidou; P Bittigau; M J Ishimaru; D F Wozniak; C Koch; K Genz; M T Price; V Stefovska; F Hörster; T Tenkova; K Dikranian; J W Olney
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

6.  Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system.

Authors:  J Ortiz; L W Fitzgerald; M Charlton; S Lane; L Trevisan; X Guitart; W Shoemaker; R S Duman; E J Nestler
Journal:  Synapse       Date:  1995-12       Impact factor: 2.562

Review 7.  Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha.

Authors:  Diego U Ferreiro; Elizabeth A Komives
Journal:  Biochemistry       Date:  2010-03-02       Impact factor: 3.162

8.  GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse.

Authors:  Sebastien Carnicella; Viktor Kharazia; Jerome Jeanblanc; Patricia H Janak; Dorit Ron
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-09       Impact factor: 11.205

9.  Evidence that opioids may have toll-like receptor 4 and MD-2 effects.

Authors:  Mark R Hutchinson; Yingning Zhang; Mitesh Shridhar; John H Evans; Madison M Buchanan; Tina X Zhao; Peter F Slivka; Benjamen D Coats; Niloofar Rezvani; Julie Wieseler; Travis S Hughes; Kyle E Landgraf; Stefanie Chan; Stephanie Fong; Simon Phipps; Joseph J Falke; Leslie A Leinwand; Steven F Maier; Hang Yin; Kenner C Rice; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2009-08-11       Impact factor: 7.217

10.  The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis.

Authors:  Natalie A Prow; David N Irani
Journal:  J Neurochem       Date:  2008-01-14       Impact factor: 5.372

View more
  43 in total

1.  TLR4-MyD88 signalling: a molecular target for alcohol actions.

Authors:  Subhash C Pandey
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Ethanol Consumption in Mice Lacking CD14, TLR2, TLR4, or MyD88.

Authors:  Yuri A Blednov; Mendy Black; Julia Chernis; Adriana Da Costa; Jody Mayfield; R Adron Harris
Journal:  Alcohol Clin Exp Res       Date:  2017-02-01       Impact factor: 3.455

Review 3.  Neuroimmune signaling: a key component of alcohol abuse.

Authors:  Jody Mayfield; Laura Ferguson; R Adron Harris
Journal:  Curr Opin Neurobiol       Date:  2013-02-22       Impact factor: 6.627

Review 4.  The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies.

Authors:  Anna Warden; Emma Erickson; Gizelle Robinson; R Adron Harris; R Dayne Mayfield
Journal:  Pharmacogenomics       Date:  2016-12-05       Impact factor: 2.533

Review 5.  Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse.

Authors:  Michael J Lacagnina; Phillip D Rivera; Staci D Bilbo
Journal:  Neuropsychopharmacology       Date:  2016-07-11       Impact factor: 7.853

Review 6.  Neuroimmune mechanisms in fetal alcohol spectrum disorder.

Authors:  Cynthia J M Kane; Kevin D Phelan; Paul D Drew
Journal:  Dev Neurobiol       Date:  2012-09-01       Impact factor: 3.964

7.  Innately activated TLR4 signal in the nucleus accumbens is sustained by CRF amplification loop and regulates impulsivity.

Authors:  Irina Balan; Kaitlin T Warnock; Adam Puche; Marjorie C Gondre-Lewis; Laure Aurelian
Journal:  Brain Behav Immun       Date:  2017-11-13       Impact factor: 7.217

8.  Role of interleukin-10 (IL-10) in regulation of GABAergic transmission and acute response to ethanol.

Authors:  A Suryanarayanan; J M Carter; J D Landin; A L Morrow; D F Werner; I Spigelman
Journal:  Neuropharmacology       Date:  2016-03-22       Impact factor: 5.250

Review 9.  Inflammatory responses to alcohol in the CNS: nuclear receptors as potential therapeutics for alcohol-induced neuropathologies.

Authors:  Cynthia J M Kane; Paul D Drew
Journal:  J Leukoc Biol       Date:  2016-07-26       Impact factor: 4.962

Review 10.  Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF.

Authors:  George R Breese; Darin J Knapp
Journal:  Alcohol       Date:  2016-02-24       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.